-
-
-
-
-
-
-
Johnson & Johnson reports Q4 and Full-Year 2025 results
-
-
-
-
-
-
-
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion
-
-
-
-
-
-
-
J&J to spin off orthopedics business, sees 2026 sales growth of over 5%
-
-
-
-
-
-
-
Guggenheim Upgrades Johnson & Johnson (JNJ) to Buy
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) Tops Q2 EPS by 9c, Beats on Revenue; Offers Strong FY25 Guidance
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) Tops Q1 EPS by 19c; adjusts forecast
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) Sets April 2nd as Expected Closing Date for Intra-Cellular Acquisition
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

